Estradiol signaling via sequestrable surface receptors

Area of Science:

• Cellular signaling pathways
• Endocrinology
• Macrophage biology

Background:

• Estradiol (E2) signaling is traditionally attributed to intracellular estrogen receptors (ERalpha and ERbeta).
• The role of non-genomic, transcription-independent E2 signaling remains an area of active investigation.
• Understanding alternative E2 signaling pathways is crucial for comprehending cellular responses in various tissues.

Purpose of the Study:

• To investigate the mechanisms of transcription-independent estradiol (E2) signaling in mouse IC-21 macrophages.
• To identify the specific receptor mediating rapid E2 effects on intracellular calcium.
• To characterize the properties of this novel E2-binding receptor.

Main Methods:

• Spectrofluorometry using Fura-2 to measure intracellular free Ca(2+) concentration ([Ca(2+)](i)).
• Pharmacological inhibition using pertussis toxin and estrogen receptor blockers (tamoxifen, raloxifene).
• Molecular and cellular techniques including RT-PCR, flow cytometry, and confocal laser scanning microscopy to identify and characterize the receptor.

Main Results:

• Estradiol (E2) and E2-BSA induced a rapid increase in [Ca(2+)](i) in IC-21 macrophages.
• The observed calcium changes were inhibited by pertussis toxin but not by tamoxifen or raloxifene.
• Evidence suggests E2 signaling is mediated by a novel G protein-coupled membrane E2 receptor, distinct from ERalpha and ERbeta.
• This novel receptor undergoes sequestration upon agonist stimulation via an energy-dependent, clathrin- and caveolin-independent pathway.

Conclusions:

• Mouse macrophages possess a transcription-independent E2 signaling pathway.
• This pathway is mediated by a novel G protein-coupled membrane E2 receptor, not intracellular ERalpha or ERbeta.
• The identified receptor exhibits unique sequestration properties, highlighting a new mechanism in E2 signal transduction.